| Nazia Parveen, DDS | |
|
8120 Croydon Ave, Los Angeles, CA 90045-3035 | |
| (424) 558-5482 | |
| Not Available |
| Full Name | Nazia Parveen |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 8120 Croydon Ave, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003566209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DDS107359 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nazia Parveen, DDS 8120 Croydon Ave, Los Angeles, CA 90045-3035 Ph: () - | Nazia Parveen, DDS 8120 Croydon Ave, Los Angeles, CA 90045-3035 Ph: (424) 558-5482 |
News Archive
The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases.
Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known. Researchers from the Institut de Pharmacologie et he Biologie Structurale (CNRS/Université Toulouse III - Paul Sabatier) have recently elucidated one of these mechanisms in prostate cancer, one of the most common cancers in men: in obese patients, the adipose tissue surrounding the prostate gland facilitates the propagation of tumor cells outside the prostate.
Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced today that it has received CE Mark approval for MANTA, the company's Large Bore Vascular Closure Device.
According to a Canadian health official test results on wild migratory ducks across Canada have not shown any link to the deadly Asian strain of the bird flu virus that has spread from Southeast Asia to Europe.
Genentech, a member of the Roche Group, confirmed that following the reviews of Avastin® (bevacizumab) in metastatic breast cancer by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), the following regulatory announcements were made by the individual health authorities:
› Verified 3 days ago
Dr. Kyung A Lim, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 827 S Berendo St Apt 202, Los Angeles, CA 90005 Phone: 213-219-2530 | |
Sonia Khullar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 132 S Vermont Avenue, Suite #210, Los Angeles, CA 90004 Phone: 213-389-2625 Fax: 213-389-4736 | |
Dr. William W Morgan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 100 Ucla Medical Plz Ste 350, Los Angeles, CA 90095 Phone: 310-794-5750 | |
Dr. Clarice Law Eyre, DMD, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 100 Ucla Medical Plz Ste 350, Los Angeles, CA 90095 Phone: 310-794-5750 | |
Dr. Arjang Vahidnia, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 7162 Beverly Blvd, #543, Los Angeles, CA 90036 Phone: 310-443-3030 | |
Dr. Adrian Sanchez, Dentist Medicare: Not Enrolled in Medicare Practice Location: 6114 York Blvd, Suite C, Los Angeles, CA 90042 Phone: 323-255-6698 | |
Dr. Bindu Vasudevan Pillai, DDS Dentist Medicare: Medicare Enrolled Practice Location: 5207 Whittier Blvd, Los Angeles, CA 90022 Phone: 323-269-0266 |